photo of

Details

Role Group Leader/Clinician-Scientist Fellow

Contact

Available for student supervision
Associate Professor Amanda Gwee MBBS FRACP DTMH PhD is the Leader of the Antimicrobials Group at the Murdoch Children's Research Institute. She is a general paediatrician, infectious diseases physician and clinical pharmacologist as well as the Clinical Lead of Research in the Department of General Medicine at the Royal Children’s Hospital Melbourne. In addition, she is an Associate Professor in the Department of Paediatrics, at the University of Melbourne.

Her research program focuses on optimising antimicrobial use and access in children and includes national and international clinical trials, pharmacokinetic/pharmacodynamic studies, and cohort studies. Amanda is passionate about improving medication use in children and is therefore involved in several international guideline/expert groups (European Society for Paediatric Infectious Diseases, WHO, Therapeutic Guidelines). She created and leads the Australasian KIDS DOSE consortium, a network of paediatric clinician researchers across 17 hospital/research institutions in Australia and New Zealand, dedicated to improving equity in access to optimal antimicrobial use in children.
Associate Professor Amanda Gwee MBBS FRACP DTMH PhD is the Leader of the Antimicrobials Group at the Murdoch Children's Research Institute. She is a general paediatrician, infectious diseases physician and clinical pharmacologist as well as the...
Associate Professor Amanda Gwee MBBS FRACP DTMH PhD is the Leader of the Antimicrobials Group at the Murdoch Children's Research Institute. She is a general paediatrician, infectious diseases physician and clinical pharmacologist as well as the Clinical Lead of Research in the Department of General Medicine at the Royal Children’s Hospital Melbourne. In addition, she is an Associate Professor in the Department of Paediatrics, at the University of Melbourne.

Her research program focuses on optimising antimicrobial use and access in children and includes national and international clinical trials, pharmacokinetic/pharmacodynamic studies, and cohort studies. Amanda is passionate about improving medication use in children and is therefore involved in several international guideline/expert groups (European Society for Paediatric Infectious Diseases, WHO, Therapeutic Guidelines). She created and leads the Australasian KIDS DOSE consortium, a network of paediatric clinician researchers across 17 hospital/research institutions in Australia and New Zealand, dedicated to improving equity in access to optimal antimicrobial use in children.

Top Publications

  • Osowicki, J, Gwee, A, Noronha, J, Palasanthiran, P, McMullan, B, Britton, PN, Isaacs, D, Lai, T, Nourse, C, Avent, M, et al. Australia‐wide point prevalence survey of the use and appropriateness of antimicrobial prescribing for children in hospital. The Medical Journal of Australia 201(11) : 657 -662 2014
    view publication
  • Gwee, A, Cranswick, N, Connell, TG, Curtis, N. Minimizing Nephrotoxicity Using Continuous Infusion of Deoxycholate Amphotericin B. The Pediatric Infectious Disease Journal 33(10) : 1098 2014
    view publication
  • Cooper, EC, Curtis, N, Cranswick, N, Gwee, A. Pristinamycin: old drug, new tricks?. Journal of Antimicrobial Chemotherapy 69(9) : 2319 -2325 2014
    view publication
  • Gwee, A, Curtis, N, Garland, SM, Connell, TG, Daley, AJ. Question 2: Which infants with congenital cytomegalovirus infection benefit from antiviral therapy?. Archives of Disease in Childhood 99(6) : 597 2014
    view publication
  • Osowicki, J, Gwee, A, Noronha, J, Palasanthiran, P, McMullan, B, Britton, PN, Isaacs, D, Lai, T, Nourse, C, Avent, M, et al. The Impact of an Infectious Diseases Consultation on Antimicrobial Prescribing. The Pediatric Infectious Disease Journal 33(6) : 669 -671 2014
    view publication

Page 17 of 20